Ibritumomab vs Anticoagulants

Interacting Drugs
Ibritumomab
vs
Anticoagulants
Security Level
Minor, Monitor Therapy
Mechanism
Anticoagulants: May enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to an increased risk of bleeding.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ibritumomab vs Anticoagulants


Other Interactions of Anticoagulants

We are Developing Our database, More results coming soon.